-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Filociclovir in Human Herpesvirus 8 (HHV-8) Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Filociclovir in Human Herpesvirus 8 (HHV-8) Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Filociclovir in Human Herpesvirus 8 (HHV-8) Infections Drug Details:...
-
Product Insights
NewNet Present Value Model: Autolus Therapeutics Plc’s AUTO-8
Empower your strategies with our Net Present Value Model: Autolus Therapeutics Plc's AUTO-8 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – XC-8 in Asthma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - XC-8 in Asthma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. XC-8 in Asthma Drug Details: XC-8 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – XC-8 in Dry Cough
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - XC-8 in Dry Cough report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. XC-8 in Dry Cough Drug Details: XC-8 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AUTO-8 in Relapsed Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AUTO-8 in Relapsed Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AUTO-8 in Relapsed Multiple Myeloma Drug Details: AUTO-8 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AUTO-8 in Refractory Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AUTO-8 in Refractory Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AUTO-8 in Refractory Multiple Myeloma Drug Details: AUTO-8 is under development...
-
Product Insights
Human Herpesvirus 8 (HHV-8) Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Human Herpesvirus 8 (HHV-8) Infections - Drugs In Development, 2023’, provides an overview of the Human Herpesvirus 8 (HHV-8) Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Human Herpesvirus 8 (HHV-8) Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Litoral Piauiense Solar PV Project 8, Brazil
Litoral Piauiense Solar PV Project 8 is proposed to be built in Piaui, Brazil. The project is at the permitting stage. Empower your strategies with our Litoral Piauiense Solar PV Project 8 report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based...
-
Product Insights
Interleukin 8 – Drugs In Development, 2023
Global Markets Direct’s Interleukin 8 provides in depth analysis on Interleukin 8 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Interleukin 8 targeted therapeutics development and features...
-
Product Insights
Integrin Beta 8 – Drugs In Development, 2023
Global Markets Direct’s Integrin Beta 8 provides in depth analysis on Integrin Beta 8 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Integrin Beta 8 targeted therapeutics...